Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Once-weekly versus thrice-weekly recombinant human erythropoietin for renal anemia in maintenance hemodialysis
ChiCTR1800014265Phase 4Not yet recruiting
- Sponsor
- Beijing Friendship Hospital
- Start
- Feb 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of erythropoietin in anemia of chronic kidney disease (2 arms), sponsored by Beijing Friendship Hospital. Primary endpoint: Hemoglobin value. Planned start Feb 2017; status: not yet recruiting.
02
Drugs
erythropoietin
03
Conditions
anemia of chronic kidney disease
Beyond the preview
Go deeper on ChiCTR1800014265.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800014265.